...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Trial
Reply New Message
Back To Forum List View
Key Players
5
KayakerBC
Aug 31, 2016 10:08PM
Icon president Re: Key Players
3
SanFrancisco99
Sep 01, 2016 12:45AM
Trial
1
Hartland
Sep 07, 2016 08:16AM
Icon president Re: Trial
5
BearDownAZ
Sep 07, 2016 09:34AM
Re: Trial

Hartland
Sep 07, 2016 11:18AM

I really have no idea how many patients are in the trial right now. I was only extrapolating from my understanding of the 3 + 3 dose escalation design. But if those assumptions are correct, then yes the 4th cycle will allow for 12 patients. Whenever Zenith provides a Q3 update (hopefully) or the AGM (not currently scheduled), hopefully we get some clarity on this.

BearDownAZ

3 Recommendations
Re: Trial

Hartland
Sep 07, 2016 07:29PM
Icon president Re: Trial
4
BearDownAZ
Sep 08, 2016 09:48AM
Re: Trial
3
Nextblockbuster
Sep 08, 2016 10:37AM
Icon president Re: Trial
4
BearDownAZ
Sep 08, 2016 11:31AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply